title: Use of denosumab in parathyroid carcinoma with refractory hypercalcemia.
authors.affiliation: From the Department of Medicine, Endocrine Unit, Hospital Putrajaya, Pusat Pentadbiran Kerajaan Persekutuan, Presint 7, 62250 Putrajaya, Malaysia tchinvoon@yahoo.com.
authors.forename: C V
authors.initials: CV
authors.lastname: Tong
authors.affiliation: From the Department of Medicine, Endocrine Unit, Hospital Putrajaya, Pusat Pentadbiran Kerajaan Persekutuan, Presint 7, 62250 Putrajaya, Malaysia.
authors.forename: Z
authors.initials: Z
authors.lastname: Hussein
authors.affiliation: From the Department of Medicine, Endocrine Unit, Hospital Putrajaya, Pusat Pentadbiran Kerajaan Persekutuan, Presint 7, 62250 Putrajaya, Malaysia.
authors.forename: N Mohd
authors.initials: NM
authors.lastname: Noor
authors.affiliation: From the Department of Medicine, Endocrine Unit, Hospital Putrajaya, Pusat Pentadbiran Kerajaan Persekutuan, Presint 7, 62250 Putrajaya, Malaysia.
authors.forename: M
authors.initials: M
authors.lastname: Mohamad
authors.affiliation: From the Department of Medicine, Endocrine Unit, Hospital Putrajaya, Pusat Pentadbiran Kerajaan Persekutuan, Presint 7, 62250 Putrajaya, Malaysia.
authors.forename: W F
authors.initials: WF
authors.lastname: Ng
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D002118:Calcium / Q000097:blood; D000069448:Denosumab; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D008207:Lymphatic Metastasis; D010257:Paraneoplastic Syndromes / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D010282:Parathyroid Neoplasms / Q000150:complications*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000069448:Denosumab; D002118:Calcium